Moving about

被引：3

作者：

Aronson, JK ^{[1
]}

机构：

[1] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 59卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.2005.02399.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：263 / 264

页数：2

共 20 条

[1] Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant [J].

Atcheson, BA ;

Taylor, PJ ;

Mudge, DW ;

Johnson, DW ;

Hawley, CM ;

Campbell, SB ;

Isbel, NM ;

Pillans, PI ;

Tett, SE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) :271-280

[2]

BECCARI E, 1937, ARCH ITAL SCI FARM, V6, P616

[3] Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects:: pharmacokinetic and pharmacodynamic effects [J].

Chaikin, P ;

Gillen, MS ;

Malik, M ;

Pentikis, H ;

Rhodes, GR ;

Roberts, DJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) :346-354

[4] Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects [J].

Csajka, C ;

Haller, CA ;

Benowitz, NL ;

Verotta, D .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) :335-345

[5] Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL [J].

de Jonge, ME ;

Huitema, AD ;

Schellens, JH ;

Rodenhuis, S ;

Beijnen, JH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) :325-334

[6]

Dost FH., 1953, BLUTSPIEGEL KINETIK

[7] THE PHARMACOKINETICS OF HALOTHANE (FLUOTHANE) ANAESTHESIA [J].

DUNCAN, WAM ;

RAVENTOS, J .

BRITISH JOURNAL OF ANAESTHESIA, 1959, 31 (07) :302-315

[8] The action strength of intravenous administered pharmaceuticals as time function. An article on mathematical treatment of pharmacological problems [J].

Gehlen, W .

NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE, 1933, 171 :541-554

[9] Studies on digitalis in ambulatory cardiac patients II The elimination of digitalis in man [J].

Gold, H ;

DeGraff, AC .

JOURNAL OF CLINICAL INVESTIGATION, 1929, 6 (04) :613-626

[10] Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes [J].

Green, B ;

Greenwood, M ;

Saltissi, D ;

Westhuyzen, J ;

Kluver, L ;

Rowell, J ;

Atherton, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) :281-290

← 1 2 →